Moderna suing Pfizer over patent for ‘foundational’ COVID-19 mRNA vaccine

0
151


Canada

2:19An in-depth look at the ‘game changing’ MRNA vaccine

Linda Aylesworth looks at the revolutionary mRNA vaccine, which allowed pharmaceutical companies to quickly develop a COVID-19 vaccine – Jan 15, 2021

Moderna is suing Pfizer and its biotech partner BioNTech for allegedly infringing on the “foundational” patent for the mRNA technology that forms the foundation of both companies’ COVID-19 vaccines.

In a press release issued Friday morning, Moderna announced the lawsuits and alleged that the Pfizer/BioNTech vaccine “infringes patents Moderna filed between 2010 and 2016 covering Moderna’s foundational mRNA technology.”

Trending Stories

Prince William, Kate Middleton moving from London to give kids ‘normal’ life

Here comes hydrogen: How this abundant element could revolutionize the way we fuel our lives 

Read more:

How Pfizer’s and Moderna’s mRNA-based COVID-19 vaccines work

“This groundbreaking technology was critical to the development of Moderna’s own mRNA COVID-19 vaccine, Spikevax,” the company said in its statement.

“Pfizer and BioNTech copied this technology, without Moderna’s permission, to make Comirnaty.”

Comirnaty is the commercial name for the Pfizer/BioNTech COVID-19 vaccine.

More to come.

© 2022 Global News, a division of Corus Entertainment Inc.